Lack of circulating bioactive and immunoreactive IGF-I changes despite improved fitness in chronic kidney disease patients following 48weeks of physical training

Growth Hormone and IGF Research

Volumn 21, Issue 1, 2011, Pages 51-56

  Gregory, Sara M ^a   Headley, Samuel A ^a   Germain, Michael ^b   Flyvbjerg, Allan ^c   Frystyk, Jan ^c   Coughlin, Mary Ann ^a   Milch, Charles M ^a   Sullivan, Sheila ^a   Nindl, Bradley C ^d  

^a SPRINGFIELD COLLEGE   (United States)

^b Pioneer Valley Dialysis Center   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

Author keywords

Exercise; Insulin like growth factor binding proteins; KIRA; Renal disease

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C;

ADULT; ANTHROPOMETRY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; EXERCISE; FITNESS; HUMAN; LONG TERM CARE; NUTRITIONAL COUNSELING; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE; TREATMENT RESPONSE;

ADULT; AGED; ATHLETIC PERFORMANCE; BODY COMPOSITION; CELLS, CULTURED; EXERCISE THERAPY; FEMALE; FLUOROIMMUNOASSAY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PHYSICAL FITNESS; RENAL INSUFFICIENCY, CHRONIC;

EID: 79951723975     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2010.12.005     Document Type: Article

References (28)

1. Chen J.W., Ledet T., Orskov H., et al. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E1149-E1155.
2. Frystyk J., Ivarsen P., Skjaerbaek C., Flyvbjerg A., Pedersen E.B., Orskov H. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int. 1999, 56:2076-2084.
3. Mahesh S., Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr. Nephrol. 2008, 23:41-48.
4. Schmitz K.H., Ahmed R.L., Yee D. Effects of a 9-month strength training intervention on insulin, insulin-like growth factor (IGF-I), IGF-binding protein (IGFBP-1) and IGFBP-3 in 30-50-year old women, Cancer. Epidemiol. Biomark. Prev. 2002, 11:1597-1604.
5. De Meyts P., Christoffersen C.T., Urso B., et al. Role of the time factor in signaling specificity: application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases. Metabolism 1995, 44:2-11.
6. Kenner K.A., Heidenreich Insulin and insulin-like growth factors stimulate in vivo receptor autophosphorylation and tyrosine phosphorylation of a 70K substrate in cultured fetal chick neurons. Endocrinology 1991, 129:301-311.
7. LeRoith D., Bondy C., Yakar S., Liu J.L., Butler A. The somatomedin hypothesis. Endocr. Rev. 2001, 22:53-74.
8. Brugts M.P., Tjiong H.L., Rietveld T., et al. Bioactive rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients. Nephrol. Dial. Transplant. 2010, 25(3):940-946.
9. Frystyk J. Exercise and the growth hormone-insulin-like growth factor axis. Med. Sci. Sports Exerc. 2010, 42:58-66.
10. Fleet M., Osman F., Komaragiri F., Fritz A., Raj D.S.C. Protein catabolism in advanced renal disease: role of cytokines. Clin. Nephrol. 2008, 70:91-100.
11. Ivarsen P., Chen J.W., Tietze I., Sandahl-Christiansen J., Flyvbjerg A., Frystyk J. Marked reductions in bioactive insulin-like growth factor-I (IGF-I) during hemodialysis. Growth Horm. IGF Res. 2010, 20(2):156-161.
12. Nindl B.C., Headley S.A., Tuckow A.P., et al. IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients. Growth Horm. IGF Res. 2004, 14:245-250.
13. Wang X.H., Du J., Klein J.D., Bailey J.L., Mitch W.E. Exercise ameliorates chronic kidey disease-induced defects in muscle protein metabolism and progenitor cell function. Kidney Int. 2009, 76:751-759.
14. Nindl B.C., Pierce J.R. Insulin-like growth factor I as a biomarker of health, fitness, and training status. Med. Sci. Sports Exerc. 2010, 42:39-49.
15. American College of Sports Medicine ACSM's Guidelines for Exercise Testing and Prescription 2006, 232-236. Lippincott Williams & Wilkins, Baltimore. 7th Edition.
16. Levey A.S., Greene T., Kusek J., Beck G.A. A simplified equation to predict glomerlular filtration rate from serum creatinine. J. Am. Soc. Nephrol. 2000, 11:155A.
17. Bruce R.A., Kusumi F., Hosmer D. Maximal oxygen uptake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am. Heart J. 1973, 85:546-562.
18. Castaneda C., Gordon P.L., Uhlln L.K., et al. Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. Ann. Intern. Med. 2001, 135:965-976.
19. Nindl B.C., Alemany J.A., Tuckow A.P., et al. Circulating bioactive and immunoreactive IGF-I remain stable in women, despite physical fitness improvements after 8 weeks of resistance, aerobic, and combined exercise training. J. Appl. Physiol. 2010, 109:112-120.
20. Nemet D., Connolly P.H., Pontello-Pescatello A.M., et al. Negative energy balance plays a major role in the IGF-I response to exercise training. J. Appl. Physiol. 2004, 96:276-282.
21. Rarick K.R., Pikosky M.A., Grediagin A., et al. Energy flux, more so than energy balance, protein intake, or fitness level, influenced insulin-like growth factor-I system responses during 7 days of increased physical activity. J. Appl. Physiol. 2007, 103:1613-1621.
22. Chen J., Hojlund K., Beck-Nielson H., Christiansen J.S., Orskov H., Frystyk J. Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects. J. Clin. Endocrinol. Metab. 2005, 90:366-371.
23. Stoving R.K., Chen J., Glintborg D., et al. Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa. J. Clin. Endocrinol. Metab. 2007, 92:2323-2329.
24. Rosendahl L., Landberg H., Flyvberg A., Frystyk J., Orskov H., Kjaer M. Physical capacity influences the response of the insulin-like growth factor and its binding proteins to training. J. Appl. Physiol. 2002, 93:1669-1675.
25. Matheny W., Merritt E., Zannikos S.V., Farrar R.P., Adamo M.L. Serum IGF-I deficiency does not prevent compensatory muscle hypertrophy in resistance exercise. Exp. Biol. Med. 2009, 234(2):276-282.
26. Yakar, Rosen C.J., Bouzsein M.L., et al. Serum complexes of insulin-like growth factor-I modulate skeletal integrity and carbohydrate metabolism. FASEB J. 2009, 23:709-719.
27. Berg U., Bang P. Exercise and circulating insulin-like growth factor-I. Horm. Res. 2004, 62:50-58.
28. Berg U., Gustafsson T., Sundberg C.J., Carlsson-Skwirut C., Bang P. Interstitial fluid in exercising skeletal muscle in women. Eur. J. Endocrinol. 2007, 157(4):427-435.